Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

NCT06554509 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Prurigo Nodularis

Interventions

DRUG: SHR-1819 Injection
DRUG: SHR-1819 Injection Placebo

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd